Selective reduction of thalamic glutathione in migraine in the absence of detectable N-acetylaspartate alterations.

This study explores the role of oxidative stress in migraine. Researchers measured metabolites in the thalamus of 131 participants. These included 36 healthy controls, 46 migraine without aura, 17 migraine with aura, and 32 tension-type headache patients. The only significant difference found was in glutathione levels. Glutathione was lower in both migraine groups compared to healthy controls. Specifically, levels were 1.76 and 1.70 in migraine groups, while controls had 2.07. No significant differences were found in N-acetylaspartate levels, a marker for neuronal integrity. The study revealed that reduced glutathione levels did not correlate with N-acetylaspartate. Glutathione showed strong diagnostic potential with 94% sensitivity and 69% specificity. These findings suggest a selective reduction of thalamic glutathione in migraine, but no detectable neuronal loss occurred. This research highlights the need for further validation of glutathione as a potential biomarker. Clinical relevance: This study suggests that reduced thalamic glutathione may help diagnose migraine.